KR

Il-Yang Pharm. Co., Ltd

USPTO Granted Patents = 14

% Expired Patents = 42.9



Trademarks = 1

Forward Citations = 74

Loading Chart...
Loading Chart...

56 inventors (with patents filed for the assignee):

goldMedal Sa Ik Bang (4 out of 4 patents)

silverMedal Sang Yoon Kim (4 out of 7 patents)

bronzeMedal Jeong Min Park (4 out of 24 patents)

4.  Dae Ho Cho (4 out of 12 patents)

5.  Juah Son (3 out of 3 patents)

6.  Ha Rum Lee (3 out of 3 patents)

7.  Sun Young Yoon (3 out of 8 patents)

8.  Yoo Rim Park (3 out of 3 patents)

9.  Yong-Seok Kim (2 out of 64 patents)

10.  Dong-Yeon Kim (2 out of 32 patents)

11.  Hong Ryeol Jeon (2 out of 10 patents)

12.  Dae-Jin Cho (2 out of 2 patents)

13.  Gong-Yeal Lee (2 out of 2 patents)

14.  Hong-Youb Kim (2 out of 2 patents)

15.  Seok-Hun Woo (2 out of 2 patents)


14 patents:

Company Overview
Il-Yang Pharm. Co., Ltd is a South Korean pharmaceutical company that specializes in the development and manufacturing of a diverse range of healthcare products. The company focuses on innovative drug formulations and is involved in various therapeutic areas, including oncology, cardiology, and infectious diseases. With a commitment to research and development, Il-Yang Pharm aims to enhance patient outcomes through advanced medical solutions and contributes to the global healthcare landscape with its high-quality pharmaceuticals.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#19 in

#826 in South Korea

#42,290 in the World

KR
KR
Forward Citations = 74

56 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Il-Yang Pharm. Co., Ltd. Retrieved from https://idiyas.com/company/il-yang-pharm-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…